Hyderabad based biotechnology company Bharat Biotech has launched the world’s first nasal Covid-19 vaccine. According to a Tweet shared by Bharat Biotech, iNCOVACC recently received approval under Restricted Use in Emergency Situation for ages 18 and above for heterologous booster doses
According to Bharat Biotech, iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19. It has two key attributes
- An intranasal vaccine stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.
- Immune responses at the site of infection (in the nasal mucosa) – essential for blocking both infection and transmission of COVID-19.
PC :https://twitter.com/BharatBiotech/photo